Targeting Gastric Cancer With Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance

Ann Surg Oncol. 2010 Jan;17(1):14-7. doi: 10.1245/s10434-009-0766-0. Epub 2009 Oct 20.

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Humans
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Receptor, ErbB-2 / immunology
  • Stomach Neoplasms / drug therapy*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab